» Articles » PMID: 11237532

Heterotypic Signaling Between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2001 Mar 10
PMID 11237532
Citations 220
Authors
Affiliations
Soon will be listed here.
Abstract

Tumors arise from cells that have sustained genetic mutations resulting in deregulation of several of their normal growth-controlling mechanisms. Much of the research concerning the origins of cancer has focused on the genetic mutations within tumor cells, treating tumorigenesis as a cell-autonomous process governed by the genes carried by the tumor cells themselves. However, it is increasingly apparent that the stromal microenvironment in which the tumor cells develop profoundly influences many steps of tumor progression. In various experimental tumor models, the microenvironment affects the efficiency of tumor formation, the rate of tumor growth, the extent of invasiveness, and the ability of tumor cells to metastasize. In carcinomas, the influences of the microenvironment are mediated, in large part, by paracrine signaling between epithelial tumor cells and neighboring stromal fibroblasts. In this review, we summarize recent advances in understanding the paracrine signaling interactions between epithelial cancer cells and associated fibroblasts and examine the effects of these bidirectional interactions on various aspects of carcinoma formation. We note, however, that paracrine signaling between other cell types within the carcinomas, such as endothelial cells and inflammatory cells, may play equally important roles in tumor formation and we will refer to these heterotypic interactions where relevant.

Citing Articles

Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular Carcinoma.

Kurowski K, Foll M, Werner T, Schilling O, Werner M, Fichtner-Feigl S J Cancer. 2025; 16(1):1-11.

PMID: 39744576 PMC: 11660125. DOI: 10.7150/jca.99944.


FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).

Solek J, Braun M, Sadej R, Romanska H Int J Oncol. 2024; 65(4).

PMID: 39219285 PMC: 11374155. DOI: 10.3892/ijo.2024.5682.


Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.

Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M Front Immunol. 2023; 14:1244345.

PMID: 37822929 PMC: 10562563. DOI: 10.3389/fimmu.2023.1244345.


Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells.

Frerichs L, Frerichs B, Petzsch P, Kohrer K, Windolf J, Bittersohl B Front Oncol. 2023; 13:1228185.

PMID: 37781195 PMC: 10534007. DOI: 10.3389/fonc.2023.1228185.


Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression.

Zahari S, Syafruddin S, Mohtar M Cancers (Basel). 2023; 15(9).

PMID: 37174117 PMC: 10177134. DOI: 10.3390/cancers15092653.